Patient No | Sex, age | HLA-B27 | Time since onset of effusion (weeks) | Number of active joints | Number of responses observed in immunoblot | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IgG | IgM | IgA | |||||||||
18 | M, 31 | + | 3 | 3 | 5 | 1 | 4 | ||||
22 | M, 23 | − | 19 | 1 | 8 | 0 | 3 | ||||
24 | M, 25 | + | 8 | 1 | 9 | 4 | 7 | ||||
25 | M, 32 | − | 4 | 3 | 10 | 5 | 6 | ||||
26 | M, 26 | + | 1 | 1 | 11 | 2 | 6 | ||||
27 | M, 25 | + | 2 | 1 | 7 | 1 | 4 | ||||
28 | M, 55 | + | 6 | 4 | 4 | 2 | 6 | ||||
31 | M, 18 | + | 9 | 2 | 9 | 1 | 3 | ||||
36 | M, 31 | ND | 8 | 2 | 8 | 3 | 4 | ||||
37 | M, 20 | + | 26 | 1 | 19 | 2 | 1 | ||||
38 | M, 23 | + | 9 | 4 | 4 | 0 | 3 | ||||
39 | M, 28 | − | 1 | 1 | 9 | 1 | 4 | ||||
40 | M, 23 | − | 11 | 5 | 21 | 1 | 7 | ||||
20 | F, 19 | − | 2 | 2 | 17 | 2 | 5 | ||||
23 | F, 27 | + | 1 | 2 | 10 | 0 | 8 | ||||
32 | F, 21 | ND | 7 | 2 | 11 | 2 | 6 | ||||
33 | F, 38 | − | 3 | 2 | 11 | 4 | 9 | ||||
34 | F, 35 | + | 1 | 3 | 23 | 1 | 20 | ||||
35 | F, 36 | ND | 1 | 1 | 21 | 4 | 14 |